Estimates Revisions Newron Pharmaceuticals S.p.A. Deutsche Boerse AG
Stocks
NP5
IT0004147952
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
06:02:07 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 9.080 EUR | +10.73% |
|
-21.39% | -65.93% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Newron Pharmaceuticals S.p.A.(NWRN)
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Newron Pharmaceuticals S.p.A.(NWRN)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- NWRN Stock
- NP5 Stock
- Consensus Newron Pharmaceuticals S.p.A.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
